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Abstract 
Lung metastasis remains the major cause of cancer related mortality in patients with breast, 
gastrointestinal, sarcoma, melanoma and kidney cancer. Here we characterize the expression of 
selectins during metastatic lung colonization and analyzed their function in the formation of 
pulmonary metastasis. E-selectin, together with VCAM-1, were detected six hours after the 
microvascular arrest of tumor cells indicating an inflammatory activation of the local endothelial 
cells. No E-selectin expression was detected in pre-metastatic lungs of mice carrying primary 
tumors. P- and L-selectin were present during initiating steps of lung colonization and correlated 
with the recruitment of platelets and leukocytes to metastatic tumor cells. Experimental 
metastasis was significantly reduced in the absence of P- or L-selectin while no attenuation of 
metastasis was observed in E-selectin-deficient mice. Collectively, selectins are upregulated 
within the metastatic microenvironment of tumor cells and the formation of a permissive 
metastatic microenvironment is facilitated by P- and L-selectin mediated interactions between 
tumor cells and blood components. E-selectin does not affect metastatic initiation in the lung 
tissue and its expression rather indicates a local activation of lung microvascular endothelial 
cells. 
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Introduction 
The formation of metastatic lesions remains the major cause for cancer-related morbidity and 
mortality. Metastasis to vital organs such as liver or lungs occurs through hematogenous 
dissemination that encompasses multiple steps including intravasation, transportation and 
survival in circulation, extravasation and colonization of distant tissues [1, 2]. In general, 
metastasis is an inefficient process, whereas tissue colonization is considered to be the rate-
limiting step [3, 4]. Tumor cells with a genetic make-up that allows them to adapt the new 
environment will successfully colonize distant organs [1, 5, 6]. Metastatic tumor cells interact 
with the local microenvironment, thereby forming a metastatic niche permissive for the 
establishment of metastatic lesions [6, 7]. Depending on the target tissue, tumor cells exhibit a 
distinct set of properties required for metastasis [1, 6, 8]. Mammary carcinoma cells adopt and 
activate different molecular pathways depending on the colonized tissue, e.g. bone or lungs [9-
11]. While the discontinuous endothelial lining of the hepatic or bone vasculature allows tumor 
cells to exit from the circulation rather rapidly, anatomy of the lung with a tight capillary bed 
seems to be an especially hostile environment for metastasizing tumor cells [12]. During 
hematogenous phase, tumor cell interactions with blood elements (cells and soluble factors) and 
the pulmonary microvascular endothelium are critical for metastasis [6, 13-16]. Specifically, the 
interaction of platelets with tumor cells enhances the tumor cell survival within the metastatic, 
pulmonary microenvironment [17-19]. The recruitment of leukocytes, mainly myeloid cells, to 
metastasizing tumor cells was shown to promote lung colonization in mice [20-23]. 
 
Metastasis-promoting interactions of tumor cells with platelets and leukocytes were shown to be 
initiated by P- and L-selectins [19, 21, 23]. The absence of P- and/or L-selectin as well as the 
blockage of any of these selectins led to a significant attenuation of metastasis [19, 21]. 
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Furthermore, the effect of heparin on metastasis is to a large extent ascribed to the inhibition of 
P- and L-selectin mediated interactions [24-26]. E-selectin is present only on activated 
endothelial cells from various vascular beds [27]. Several studies demonstrated that the hepatic 
sinusoidal endothelium is activated during the initial phase of metastatic liver colonization [28-
30]. This endothelial activation was associated with an upregulation of cell adhesion molecules 
including E-selectin and VCAM-1, that was similar to a local inflammatory reaction [28]. 
Upregulation of E-selectin expression in the liver was associated with enhanced formation of 
metastasis [31, 32].  In this work we aimed to characterize the expression and the function of all 
three selectins (E-, P-, and L-) during lung colonization in an experimental metastasis model.  
 
Material and methods 
Cell culture 
MC-38 and MC-38GFP murine colon adenocarcinoma cells were grown as described previously 
[19]. Human colon carcinoma cells, LS180 tumor cells were grown in DMEM medium 
containing 10% FCS. Hybridomas producing L-selectin antibody (MEL-14 clone from ATCC) 
were grown and the antibody purified as described previously [21]. 
 
Experimental metastasis 
LS180 tumor cells (350’000 cells, passage 2-4) were injected into the lateral tail vein of Rag2 
deficient (Rag2 -/-) or selectin deficient mice in a Rag2 background (Esel-/-/Rag2-/-; Psel-/-
/Rag2-/-; or Lsel -/-/Rag2-/-). Mice (groups of 5-8) were euthanized 6 weeks later, and lungs 
were dissected. Isolated genomic DNA was analyzed for human ALU sequences by densitometry 
as previously described [24]. 
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C57BL6 mice (Jackson Lab) were intravenously injected with 300’000 of MC-38GFP cells 
(passage 2-4). In some experiments, MC-38GFP cells were injected intravenously into C57BL6 
mice bearing subcutaneous MC-38 tumors. Subcutaneous injection of 2 x 106 of MC-38 cells in 
the right flank was performed two weeks prior to intravenous injection of MC-38GFP cells. Mice 
were euthanized at indicated time points, and PFA fixed lungs dissected for histological studies. 
 
Spontaneous metastasis  
3LL tumor cells (1 x 106 cells) constitutively expressing firefly luciferase and GFP were 
subcutaneously injected in the right flank of C57BlJ6 mice. Mice (groups of 6-7) were 
euthanized at different time points after tumor cell inoculation. Lung metastasis was assessed by 
histology and detection of GFP positive cells.  
 
Detection of selectins and VCAM-1 
Lungs isolated from mice injected with MC-38GFP cells were frozen in O.C.T. (Sakura) and 8-
10 µm lung sections stained with monoclonal antibodies against murine E-selectin, P-selectin, 
VCAM-1 (BD Biosciences) or L-selectin, MEL-14. Specific staining was detected by goat-anti-
rat-Alexa568 antibody (Invitrogen). Images were obtained with a confocal microscope (SP5, 
Leica) using a 63x objective (NA 1.4, oil immersion) and subsequently analyzed with Imaris 
Software (Bitplane). Image stacks of 42-43 images with approximately 6 µm in the z-axis were 
acquired with similar settings between different conditions. Positive voxels for respective 
antibodies were quantified in a microenvironment centered on a metastasizing MC-38GFP tumor 
cell within a volume of 15 000 µm3 by cropping image-stacks to 50 x 50 µm in x- and y-axis with 
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Imaris software (Bitplane). For the semiquantitative analysis we analyzed 10-15 images per each 
staining usually obtained from at least two different mice.  
 
Statistical analysis 
Statistical significance was calculated with the Student’s t test or by analysis of variance 
(ANOVA) where appropriate.  
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Results 
E-selectin in the pulmonary metastatic microenvironment 
E-selectin is expressed on activated endothelial cells and was shown to be upregulated during the 
metastatic colonization of the liver [33]. To study the E-selectin expression during lung 
colonization, we used intravenous injection of MC-38GFP tumor cells that metastasize to the 
lungs. Mice were terminated at different time points after the tumor cell injection and lungs were 
evaluated for the presence of E-selectin. A strong expression of E-selectin was observed in the 
vicinity of metastatic tumor cells 6 and 12 hours after the tumor cell injection, while the 
expression diminished after 48 hours (Fig. 1). In the lungs of mice without tumor cell injection no 
E-selectin expression was detected (data not shown). The specific activation of endothelium in 
the vicinity of tumor cells was further confirmed by detection of VCAM-1 expression (Fig. 2). 
Similar to the E-selectin upregulation, VCAM-1 expression was increased between 6 and 24 
hours after the injection of MC-38GFP cells (Fig. 2). These findings indicate that tumor cell 
interactions with the microenvironment induce an inflammatory-like activation of endothelial 
cells during the initial steps of lung colonization. 
 
E-selectin expression in the pre-metastatic lung 
Several recent studies described the formation of a pre-metastatic niche in distant organs that 
preceded the dissemination of tumor cells [34-36]. Different soluble factors secreted by the 
primary tumor, including VEGF-A, LOX and TGFβ, were identified to be responsible for 
generation of a pre-metastatic niche that is associated with the upregulation of molecules such as 
MMP9 and fibronectin [34, 36, 37]. To test whether lung endothelial activation can be observed 
in a tumor-bearing mouse, we analyzed lungs for E-selectin expression from mice with two 
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weeks old subcutaneous MC-38 tumors. No spontaneous metastasis to the lungs has been 
observed. In addition, no significant alteration in E-selectin expression was observed in mice 
with subcutaneous tumors (mean E-selectin voxels count = 8427 in untreated C57BL6 mice vs. 
6029 in mice with subcutaneously grown MC-38 tumor, p = 0.24 by Student t-test, Fig. 3A). To 
determine whether any activation of pulmonary vasculature is affected by the presence of a 
primary tumor, we injected MC-38GFP cells into the lateral tail vein of mice bearing established 
subcutaneous MC-38 tumors. E-selectin expression during the first 24 hours after tumor cell 
injection has showed a similar time course as observed before in mice without subcutaneous 
tumors (Fig. 3B).  
To analyze the contribution of E-selectin to metastasis we used a spontaneous metastasis model 
using mouse Lewis Lung carcinoma cells (3LL), which upon subcutaneous injection metastasize 
to the lungs. During the first 17 days after tumor cell inoculation, there was no evidence of lung 
metastasis. At this time point E-selectin expression in the pulmonary tissue was not significantly 
upregulated (mean E-selectin voxels = 8427 in lungs of mice without tumor cell inoculation vs. 
5090 in lungs of mice with subcutaneous 3LL tumors 17 days after inoculation, p = 0.44 by 
ANOVA). Twenty four days after the subcutaneous injection of 3LL cells, nearly all examined 
lungs showed metastatic nodules (Supplementary Figure 1). Increased expression of E-selectin 
was detected only in the proximity of already established metastatic foci (mean E-selectin voxels 
= 35 413, p=0.01 by ANOVA, Fig. 3C). Collectively, these observations indicate that E-selectin 
is detected only in the proximity of disseminated tumor cells in lungs and is not upregulated by 
distant mediators in an endocrine fashion.  
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Detection of P- and L-selectin in the vicinity of metastatic tumor cells 
Experimental metastasis of several tumor cells was shown to be dependent on P- and L-selectin-
mediated interactions within the vasculature [16, 19, 21, 24, 38, 39]. P-selectin on activated 
platelets facilitates the binding to mucins on tumor cell surfaces, thereby protecting tumor cells 
from immune-mediated lysis [17, 18, 24]. L-selectin deficiency has led to reduced metastasis that 
was associated with a decreased recruitment of leukocytes to metastatic tumor cells in the lung 
tissues [21]. Recently, P- and L-selectin mediated interactions were shown to support metastasis 
by creation of a permissive metastatic microenvironment [23]. To determine the time dependence 
of P- and L-selectin appearance in the metastatic microenvironment, lung sections of mice 
injected with MC-38GFP cells were analyzed at different time points. Early tumor cell detection 
in the pulmonary vasculature was associated with an accumulation of P-selectin signal in a form 
of an anuclear cloak around tumor cells as early as 30 minutes post-tumor cell injection (Fig. 
4A). P-selectin staining in the vicinity of intravascular tumor cells was rapidly reduced within 3 
to 6 hours post-tumor cell injection and was eliminated within 24 hours (Fig 4B). The observed 
time course was similar to the accumulation of platelets around MC-38GFP cells during lung 
colonization [21]. This finding suggests that the detected P-selectin was mainly derived from 
activated platelets. However, some intracellular staining of P-selectin in lungs of mice without 
tumor cell injection was observed, that corresponded to endothelial P-selectin (data not shown).  
L-selectin positive cells were counted in the vicinity of metastatic tumor cells (Fig. 5A,B). An 
enhanced recruitment of L-selectin positive cells was detected between 12 and 24 hours after 
tumor cell injection. Likewise, the quantification of L-selectin positive signal in the vicinity of 
MC-38GFP positive cells showed an increased detection between 12 and 24 hours after tumor 
cell arrest in the pulmonary microvasculature (Fig. 5C). Since L-selectin expression is restricted 
to leukocytes [27], the observed association of L-selectin positive cells corresponded to a 
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recruitment of leukocytes. This is in agreement with the previously observed accumulation of 
Mac-1 positive leukocytes during early lung colonization [21]. Taken together, P-selectin is 
detected in the pulmonary metastatic microenvironment of tumor cells as early as 30 minutes 
after their intravascular injection, while the presence of L-selectin-positive leukocytes is observed 
mainly at time-points beyond 12 hours. 
 
Effect of E-selectin on pulmonary metastasis 
The finding that E-selectin expression is upregulated in the metastatic microenvironment of 
pulmonary arrested tumor cells regardless of an existing primary tumor (Fig. 3) suggested that E-
selectin expression is rather a consequence of local endothelial activation. Therefore we aimed to 
analyze the contribution of E-selectin to metastasis in E-selectin deficient mice. Since both 
murine MC-38GFP [19] and 3LL cells (manuscript in preparation) do not express E-selectin 
ligands, we used human LS180 tumor cells that carry selectin ligands for all three selectins [40]. 
LS180 cells were injected in a Rag2-/- immune-deficient mice either with or without E-selectin 
Esel-/-/Rag2-/- and terminated after six weeks. No significant reduction of metastasis was 
detected in E-selectin deficient mice when compared to control Rag2-/- mice (Fig. 6). By 
contrast, a strong attenuation of metastasis was observed in mice deficient in L- or P-selectin as 
described previously [19, 24]. These results indicate that endothelial E-selectin expression in the 
pulmonary tissue has a minor or redundant function during metastasis. 
 
 
Discussion 
In this work we compared the relative contributions of E-, P- and L-selectin to lung metastasis. E-
selectin was upregulated in the metastatic microenvironment several hours after the 
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microvascular arrest of tumor cells. The detected E-selectin expression was concomitant to the 
upregulation of VCAM-1, indicating an inflammatory activation of the metastatic 
microenvironment. This notion is further supported by the observed recruitment of inflammatory 
cells (monocytes, neutrophil-granulocytes) to metastatic tumor cells [21-23]. A similar 
inflammatory activation was also observed in the sinusoidal endothelial cells of the liver during 
the metastatic colonization that led to the upregulation of E-selectin [33]. Inhibition of E-selectin 
expression by antisense oligonucleotides or by function-blocking anti-E-selectin antibody 
attenuated experimental liver metastasis of tumor cells injected in the spleen of a mouse [31, 41]. 
Our results indicate that E-selectin expression does not directly promote metastatic colonization 
of the lungs, but rather reflects the inflammatory activation of endothelial cells. Thus, E-selectin 
may contribute to initiation of metastasis in certain tissues, like liver, while having a limited role 
in lungs. In another set of studies, E-selectin was shown to contribute to transendothelial 
migration of tumor cells in vitro [42, 43]. Tumor cell extravasation is considered to be an 
important step during lung colonization [10]. In the absence of E-selectin, we observed no 
reduction of metastasis indicating that E-selectin expression is unlikely to facilitate tumor cell 
extravasation during lung colonization. 
The role of E-selectin expression by the initial microvascular arrest of metastatic tumor cells was 
studied in vitro and in vivo [40, 44-46]. Conversely, our results show that E-selectin is not present 
in the pulmonary microvasculature during the initial arrest of metastatic tumor cells. Moreover, 
E-selectin was not detected in the microenvironment of metastatic tumor cells during the first 
three hours after the arrest in the microvasculature in mice with primary tumors (Fig. 3). The 
contribution of E-selectin to metastasis was studied in a cytokine-induced experimental lung 
metastasis model [40]. Treatment of human colorectal tumor cells, carrying E-selectin ligands, 
with a soluble E-selectin prior to the intravenous injection led to a reduction of metastasis in IL-1 
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treated mice. However, the induced E-selectin expression by a high cytokine dose unlikely 
reflects the natural process of metastatic lung colonization. In another study, a peptide mimic of 
E-selectin ligands was shown to reduce experimental lung metastasis [46]. Yet, the peptide was 
not specific only for E-selectin, but also bound to L- and P-selectin [46]. Here we provide 
evidence that L- and P-selectin contribute to the colonization of lungs (Fig. 6) and both mediate 
initial steps of metastasis [19, 21, 23, 39].   
P-selectin is known to mediate the interaction of tumor cells with platelets, thereby enhancing 
experimental lung colonization [24]. Platelets are important enhancers of hematogenous 
dissemination, intravascular tumor cell survival and tissue colonization [14, 17, 18, 24, 47-49]. 
Here, we show that P-selectin is detected during the first hours of metastatic lung colonization 
that is in agreement with the previously observed P-selectin dependent accumulation of platelets 
[21, 24]. This finding indicates that P-selectin-mediated interactions primarily affect metastasis 
during the initiation of tissue colonization. Heparin was shown to inhibit P- and L-selectin and its 
application at the time of tumor cell injection strongly attenuated metastasis [24, 25, 50]. 
Recently, we provided evidence that P-selectin-mediated interactions between tumor cells and 
platelets facilitate the inflammatory activation of microvascular endothelial cells and the 
formation of a permissive metastatic microenvironment [23].  
Temporal blockage of L-selectin function caused an attenuation of experimental metastasis to 
similar levels as observed in L-selectin deficient mice, suggesting a critical contribution of 
leukocytes during the initiation phase of metastasis [21]. Furthermore, the absence of L-selectin 
resulted in a decreased recruitment of myeloid cells to metastasizing tumor cells [21]. In this 
study, we show that L-selectin accumulation in the metastatic microenvironment timely 
correlated with the recruitment of leukocytes. Myeloid cells were shown to support tumor 
progression and metastatic colonization in different mouse models [23, 34, 36, 51]. Thus, it is 
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conceivable that L-selectin participates in the recruitment of myeloid cells to metastatic cells and 
thereby facilitates the permissive metastatic microenvironment.  
Presented data together with several recent studies support the hypothesis that the 
microenvironment of metastatic tumor cells undergoes an inflammatory activation during lung 
colonization [21-23, 34, 52]. Activation of endothelial cells results in an upregulation of cell 
adhesion molecules, E-selectin and VCAM-1 and secretion of chemokines including CCL5 that 
facilitates the recruitment of monocytes [23]. Furthermore this endothelial activation is dependent 
on P-selectin mediated interactions of platelets with tumor cells. Finally, the recruitment of 
myeloid cells and monocytes to the metastatic sites is dependent on L-selectin mediated 
interactions that further contribute to the formation of a metastatic niche [21, 23]. From the 
timely sequence of events during metastatic initiation, P-selectin seems to facilitate initial steps, 
while L-selectin and possibly E-selectin participate in the subsequent steps of metastasis 
progression. Thus, a selective targeting of selectins represents a valid therapeutic approach for 
inhibition of hematogenous metastasis.  
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Figure legends 
Figure 1 E-selectin expression during metastatic colonization of the lungs. C57Bl6 mice 
were intravenously injected with MC-38GFP cells and lungs analyzed at indicated time points. 
A) Representative images of E-selectin expression (red) in the pulmonary microenvironment of 
metastasizing tumor cells (green). Nuclei were stained with DAPI (blue). Bar = 20 µm. B) 
Semiquantitative analysis of E-selectin expression around metastatic MC-38GFP cells during 
early pulmonary colonization was performed by Imaris software. 
 
Figure 2 VCAM-1 expression during metastatic colonization of the lungs. C57Bl6 mice 
were intravenously injected with MC-38GFP cells and lungs analyzed at indicated time points. 
A) Representative images of VCAM-1 expression (red) in the metastatic microenvironment of 
tumor cells (green). Nuclei were stained with DAPI (blue). Bar = 20 µm. B) Semiquantitative 
analysis of VCAM-1 expression around metastatic MC-38GFP cells during early pulmonary 
colonization was performed by Imaris software. 
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Figure 3 E-selectin expression in pre-metastatic lungs. A) Mice subcutaneously injected 
with MC-38 tumor cells were analyzed for the expression of E-selectin in the lungs after 14 days 
(MC-38 tumor) and compared to lungs of mice without tumor (no tumor). Mice bearing 
subcutaneous MC-38 tumors for 14 days were injected intravenously with MC-38GFP and lungs 
analyzed 6 hours later (MC-38 tumor +6 h i.v.); * = p < 0.05 by ANOVA. B) Mice bearing 
subcutaneous MC-38 tumors for 14 days were intravenously injected with MC-38GFP cells and 
expression of E-selectin in the vicinity of metastasizing tumor cells followed over time. 
Semiquantitative analysis of E-selectin detection by metastatic MC-38GFP cells was evaluated 
by Imaris software (p < 0.001 by ANOVA). C) Lungs of mice carrying subcutaneous 3LL tumors 
that spontaneously metastasize to the lungs were analyzed for E-selectin expression over time and 
compared to lungs from healthy, tumor-naïve mice (no tumor). Mice bearing 3LL tumors for 17 
days (3LL tumor 17 D), but without detectable metastasis, showed no significant difference 
compared to tumor-naïve controls. However, E-selectin expression in the microenvironment of 
metastasizing 3LL tumor cells was induced beyond 21 days (3LL tumor 21 D) and significantly 
increased at 24 days (3LL tumor 24 D). ** = p < 0.01, by ANOVA.  
 
Figure 4 P-selectin expression in the vicinity of tumor cells metastasizing to the lungs.  
C57Bl6 mice were intravenously injected with MC-38GFP cells and lungs analyzed for the P-
selectin expression at indicated time points. a) Representative images of P-selectin (red) detected 
in the metastatic microenvironment of tumor cells (green). Nuclei were stained with DAPI (blue). 
Bar = 20 µm. b) A relative quantification of P-selectin presence around metastatic MC-38GFP 
cells was performed by Imaris software. P-selectin detection was significantly elevated at 30 
minutes and 3 hours after tumor cell injection (30 minutes, p < 0.001; 3 hours, p < 0.05 by 
ANOVA). 
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Figure 5 L-selectin detection in the pulmonary microenvironment of metastatic tumor 
cells. C57Bl6 mice were intravenously injected with MC-38GFP cells and lungs analyzed for the 
presence of L-selectin at indicated time points. A) L-selectin positive cells were quantified in the 
microenvironment of hematogenously metastasizing tumor cells. The association of L-selectin 
positive cells with MC-38GFP cells during early lung colonization was analyzed. Statistically 
significant increase in expression at 12, 18 and 24 hours when compared to earlier timer points 
was observed (12 hours, p < 0.05, 18 and 24 hours p < 0.001, determined by ANOVA). B) 
Representative images of L-selectin positive cells (red) in the pulmonary microenvironment of 
metastasizing MC38-GFP cells (green) 18 and 24 hours after intravenous injection. Nuclei were 
stained with DAPI (blue). Bar = 20 µm. C) Relative quantification of L-selectin staining around 
metastatic MC-38GFP cells during the first 48 hours of lung colonization was performed by 
Imaris software. L-selectin detection was significantly increased at 18 and 24 hours after tumor 
cell injection (p < 0.001 by ANOVA). 
 
Figure 6  Experimental metastasis in selectin deficient mice. LS180 cells were 
intravenously injected into RAG2 deficient mice (wt), P-selectin (Psel-/-), L-selectin (Lsel-/-) or 
E-selectin (Esel-/-) deficient mice in a Rag2 deficient background, respectively. After 5 weeks, 
lungs were harvested and metastasis was assessed by quantification of human ALU sequences. 
ANOVA with a Bonferroni post-hoc test was performed for determination of a statistical 
significance. 
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